Profile № 19, Oncology

Tumor markers are compounds that are produced by tumor cells or the body in response to tumor development.

Elevated concentrations of tumor markers can not serve as an absolute proof of the presence of a tumor, since they are often detected in diseases of a non-tumor nature. The importance of tumor markers can not be overestimated, and their definition should be considered as an additional diagnostic method with relative applicability and accuracy for each diagnosis.

The use of oncomarkers in clinical diagnosis:

Screening

- Diagnosis and monitoring of the course of the disease

- evaluation of the effectiveness of the therapy (radio, chemotherapy, hormone therapy, surgical treatment)

- Long-term follow-up with the aim of early detection of relapses and metastases of the tumor.

PSA general (prostatic specific antigen common)
PSA free (prostatic specific antigen free)
2proPSA
Cancer-embryonic antigen (CEA)
CA 15-3 (Carbohydrate antigen 15-3)
CA19-9 (Carbohydrate Antigen 19-9)
CA-125 (carbohydrate antigen 125)
CA72-4 (Carbohydrate Antigen 72-4)
AFP (alpha-fetoprotein)
HCG (human chorionic gonadotropin)
NSE (nonspecific enolase)
Β2-microglobulin
Thymidine kinase
Protein S-100
TPA-M (cytokeratins 8,18,19)
The number 21-1 (cytokeratins)
Piruvatkinase
The human epididymis protein (HE4)
Squamous cell carcinoma antigen (SCCA)